Evidence map›Paper›PMID 38569913›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Association between the Decrease in Medical Visit Frequency and Chronic Disease Worsening in the Early Stages of COVID-19 - A Longitudinal Study.

Takeshi Takakubo, Yuko Odagiri, Masaki Machida, Tomoko Takamiya, Noritoshi Fukushima, Hiroyuki Kikuchi, Toshio Hayashi, Shiho Amagasa, Shigeru Inoue

Open access · diamondAbstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Takeshi TakakuboDepartment of Preventive Medicine and Public Health, Tokyo Medical University, Japan.
Yuko OdagiriDepartment of Preventive Medicine and Public Health, Tokyo Medical University, Japan.
Masaki MachidaDepartment of Preventive Medicine and Public Health, Tokyo Medical University, Japan.
Tomoko TakamiyaDepartment of Preventive Medicine and Public Health, Tokyo Medical University, Japan.
Noritoshi FukushimaDepartment of Preventive Medicine and Public Health, Tokyo Medical University, Japan.
Hiroyuki KikuchiDepartment of Preventive Medicine and Public Health, Tokyo Medical University, Japan.
Toshio HayashiDepartment of Preventive Medicine and Public Health, Tokyo Medical University, Japan.
Shiho AmagasaDepartment of Preventive Medicine and Public Health, Tokyo Medical University, Japan.
Shigeru InoueDepartment of Preventive Medicine and Public Health, Tokyo Medical University, Japan.
Tokyo Medical University · JPTeikyo University · JPTokyo Medical University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective This longitudinal study aimed to clarify the changes in the medical treatment behavior of Japanese patients with chronic diseases during the early phase of the coronavirus disease 2019 (COVID-19) pandemic and examine the factors associated with disease worsening. Methods Subjects with chronic diseases were selected from a panel survey that started at the beginning of the COVID-19 pandemic consists of 2,400 participants recruited via the Internet. Medical treatment behaviors (decrease in medical visit frequency, inability to take regular medications, and utilization of telephone/online medical care), psychological distress, and sociodemographic factors were evaluated at baseline (May 2020) and at the follow-up survey (February 2021). A worsening of chronic diseases was defined as those who answered "yes" to the question, "Has-the-condition-of-the-chronic-disease-worsened?". The factors related to the worsening of chronic diseases at follow-up were examined. Results A total of 514 participants (mean age 61.6±12.9 years) were analyzed. The percentage of participants who reported decreasing medical visit frequency was 34% at the baseline and 16.5% at follow-up, and those who reported a worsening of chronic diseases was 5.1% and 5.1%, respectively. A worsening of chronic diseases at follow-up was significantly associated with a younger age, a decreased frequency of medical visits, unemployment, a history of smoking, and psychological distress. Conclusions A decreased frequency of medical visits was observed among one-third of the participants with chronic disease in the early stage of the pandemic, and it reduced by half at follow-up. In the early stages of an emerging infectious disease pandemic, decreased regular hospital/clinic visits can lead to a worsening of chronic diseases. Those who had psychological distress, unemployment, and a history of smoking were vulnerable to a worsening chronic disease.

Indexed as

COVID-19Disease ProgressionAdultAgedChronic DiseaseFemaleHumansJapanLongitudinal StudiesMaleMiddle AgedPandemicsSARS-CoV-2Surveys and Questionnaireschronic diseaseCOVID-19decrease in medical visit frequencyinability to take regular medicationsmedical visit behaviorworsening of chronic diseases

Identifiers

PMID38569913
PMCPMC11239260
OpenAlexW4393371165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.